Latest Shareholder Support News

Page 12 of 49
Regener8 Resources has announced a $2.03 million entitlement offer at a 41% discount, aiming to accelerate exploration and acquisition of its Srebrenica North Project. Eligible shareholders can subscribe at one new share for every two held, positioning the company for its next growth phase.
Maxwell Dee
Maxwell Dee
16 Mar 2026
Shriro Holdings Limited has announced a $15 million off-market share buy-back at $0.81 per share, representing nearly 26% of its issued capital. The move aims to return excess capital to shareholders while supporting the company’s capital-light growth model.
Victor Sage
Victor Sage
12 Mar 2026
HighCom Limited has successfully raised nearly $800,000 through a Share Purchase Plan, adding to a prior $7 million placement to fund product upgrades and sales growth.
Maxwell Dee
Maxwell Dee
10 Mar 2026
Little Green Pharma Ltd (ASX: LGP) has proposed a full acquisition of Cannatrek Ltd via a scheme of arrangement, creating a vertically integrated medicinal cannabis group with pro forma FY26 revenues exceeding AUD 100 million. The scheme, supported by an independent expert, offers liquidity and strategic growth opportunities amid regulatory and market risks.
Ada Torres
Ada Torres
5 Mar 2026
Eden Innovations Ltd reports a $1.43 million half-year profit, reversing prior losses thanks to a $4.45 million property sale and significant debt reduction, while advancing international commercialisation of its concrete and fuel technologies.
Maxwell Dee
Maxwell Dee
27 Feb 2026
Nexalis Therapeutics reported a widening loss of $1.83 million for 2025, reflecting increased investment in product development and marketing. Despite the loss, the company boosted its cash reserves through equity raises and borrowings.
Ada Torres
Ada Torres
27 Feb 2026
Avecho Biotechnology reported a 9.3% revenue increase alongside a 41.5% rise in net loss for 2025, while progressing its Phase III CBD insomnia trial and securing a significant licensing agreement with Sandoz.
Ada Torres
Ada Torres
27 Feb 2026
Actinogen Medical has successfully completed a $16.8 million capital raising, combining a $12 million placement with a $4.8 million share purchase plan, to fund its pivotal Alzheimer’s disease trial and other 2026 initiatives.
Ada Torres
Ada Torres
27 Feb 2026
ARC Funds Limited posted a $1 million loss for the half-year ending December 2025, while significantly increasing revenues and expanding its ownership in The Term Deposit Shop to 74.48%. The company raised nearly $1.9 million to support growth initiatives amid ongoing operational challenges.
Claire Turing
Claire Turing
27 Feb 2026
ClearView Wealth Limited has entered a definitive scheme implementation deed with Zurich Financial Services Australia Limited, agreeing to a $415 million acquisition at a 21.5% premium to its recent share price. The deal, supported by major shareholders and subject to regulatory and court approvals, offers shareholders a cash consideration of 65 cents per share plus potential dividends and ticking fees.
Victor Sage
Victor Sage
24 Feb 2026
Morella Corporation has raised A$2.1 million through a placement to fund drilling at its Mt Edon Rubidium–Lithium Project, marking a key step toward defining a maiden mineral resource estimate.
Maxwell Dee
Maxwell Dee
23 Feb 2026
Argo Global Listed Infrastructure Limited has reported a sharp 72% decline in half-year profit for the period ending December 2025, driven by unrealised fair value losses on its investment portfolio. Despite this, the company has declared a higher fully franked interim dividend of 4.5 cents per share.
Victor Sage
Victor Sage
23 Feb 2026

Browse the archive

Full archive